PT830132E - Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao - Google Patents

Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao

Info

Publication number
PT830132E
PT830132E PT96913473T PT96913473T PT830132E PT 830132 E PT830132 E PT 830132E PT 96913473 T PT96913473 T PT 96913473T PT 96913473 T PT96913473 T PT 96913473T PT 830132 E PT830132 E PT 830132E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
active ingredient
composition containing
preparation process
tiagabine hydrochloride
Prior art date
Application number
PT96913473T
Other languages
English (en)
Inventor
Helle Weibel
Jorgen Ryhl Svensson
Lars Nygaard
Tina Meinertz Andersen
Thyge Borup Hjorth
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PT830132E publication Critical patent/PT830132E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96913473T 1995-05-05 1996-04-29 Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao PT830132E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05

Publications (1)

Publication Number Publication Date
PT830132E true PT830132E (pt) 2002-07-31

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96913473T PT830132E (pt) 1995-05-05 1996-04-29 Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao

Country Status (26)

Country Link
US (1) US5866590A (pt)
EP (1) EP0830132B1 (pt)
JP (1) JP3195360B2 (pt)
KR (1) KR100440354B1 (pt)
CN (1) CN1092959C (pt)
AR (1) AR003418A1 (pt)
AT (1) ATE211911T1 (pt)
AU (1) AU707508B2 (pt)
BR (1) BR9608120A (pt)
CA (1) CA2220019C (pt)
CZ (1) CZ292256B6 (pt)
DE (1) DE69618586T2 (pt)
DK (1) DK0830132T3 (pt)
EG (1) EG23781A (pt)
ES (1) ES2171669T3 (pt)
HU (1) HU223075B1 (pt)
IL (1) IL118142A (pt)
MX (1) MX9708394A (pt)
MY (1) MY115016A (pt)
NO (1) NO318599B1 (pt)
NZ (1) NZ307159A (pt)
PL (1) PL183678B1 (pt)
PT (1) PT830132E (pt)
UA (1) UA43402C2 (pt)
WO (1) WO1996034606A1 (pt)
ZA (1) ZA963478B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
ES2172179T3 (es) * 1997-08-01 2002-09-16 Elan Corp Plc Composiciones farmaceuticas de liberacion controlada que contienen tiagabina.
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
EP1017386A1 (en) * 1997-10-02 2000-07-12 H. Lundbeck A/S GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
JP2004506609A (ja) * 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
AU2013257707A1 (en) * 2012-05-08 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy
JP6793651B2 (ja) * 2015-08-28 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
ZA963478B (en) 1996-11-13
DK0830132T3 (da) 2002-04-29
UA43402C2 (uk) 2001-12-17
CZ338897A3 (cs) 1998-03-18
MX9708394A (es) 1998-02-28
NZ307159A (en) 1998-10-28
DE69618586T2 (de) 2002-09-05
PL183678B1 (pl) 2002-06-28
ES2171669T3 (es) 2002-09-16
HUP9802741A2 (hu) 1999-03-29
CN1183721A (zh) 1998-06-03
IL118142A (en) 1999-11-30
BR9608120A (pt) 1999-02-09
WO1996034606A1 (en) 1996-11-07
CZ292256B6 (cs) 2003-08-13
ATE211911T1 (de) 2002-02-15
MY115016A (en) 2003-03-31
CA2220019A1 (en) 1996-11-07
EP0830132B1 (en) 2002-01-16
EP0830132A1 (en) 1998-03-25
DE69618586D1 (de) 2002-02-21
NO975076L (no) 1997-11-04
AU707508B2 (en) 1999-07-15
JP3195360B2 (ja) 2001-08-06
EG23781A (en) 2007-08-13
NO318599B1 (no) 2005-04-18
IL118142A0 (en) 1996-09-12
NO975076D0 (no) 1997-11-04
PL323138A1 (en) 1998-03-16
CN1092959C (zh) 2002-10-23
JPH10505359A (ja) 1998-05-26
KR100440354B1 (ko) 2004-09-18
HU223075B1 (hu) 2004-03-01
AU5644196A (en) 1996-11-21
HUP9802741A3 (en) 1999-04-28
CA2220019C (en) 2007-12-11
AR003418A1 (es) 1998-08-05
US5866590A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
BR9506147A (pt) Novos derivados de eritromicina seu processo de preparação e sua aplicação como medicamentos
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
PT830132E (pt) Composicao farmaceutica contendo hidrocloruro de tiagabina como ingrediente activo e seu processo de preparacao
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
EP0727217A3 (en) Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
EE04399B1 (et) Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis
PT1183029E (pt) Preparado farmaceutico contendo contendo o principio activo diamorfina e sua utilizacao num processo para o tratamento da dependencia de opiaceos
ATE284399T1 (de) Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
EE201000018A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
BR9707709A (pt) Derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
EE200000759A (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
EE200000065A (et) Bioloogiliselt aktiivseid makromolekule ja vett sisaldavad aerosoolpreparaadid ja nende aerosoolide saamise meetod
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
BR9502540A (pt) Processo para encapsular ingrediente ativo util na agricultura e composiçao útil na agricultura
PT1004592E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
PT981332E (pt) Composicao farmaceutica compreendendo lipossomas liofilizados encapsulando um principio activo essencialmente insoluvel em agua e processo de preparacao desta composicao
BR9805297B1 (pt) derivados de 1,3,8-triazaspiro[4,5]decan-4-ona, seu referido processo de preparação e medicamento.
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
BRPI0208998A2 (pt) formulação farmacêutica com gosto dissumulado e seu processo de preparo